Dr Reddys Laboratories RDY
NYSE RDY
$14.90 +0.38 (+2.62%)
At close: Nov 6, 2026 · 4:00 PM EST

Dr Reddys Laboratories (RDY) Amortization - Intangibles (2013 - 2014)

Updated

Dr Reddys Laboratories' Amortization - Intangibles came in at $9 million for fiscal Q4 2014 (quarter ended Mar 31, 2014), down 18.2% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Amortization - Intangibles (2013 - 2014) Analysis & Trends

Over the trailing twelve months to Mar 31, 2014, Dr Reddys Laboratories reported Amortization - Intangibles of $590 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn
10 Dr Reddys Laboratories 12.40 Bn 11.74 Bn 472.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 9.00 Mn
Dec 31, 2013 11.00 Mn
Jun 30, 2013 562.00 Mn
API Access

Dr Reddys Laboratories Amortization - Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-intangibles&ticker=RDY&period=max&api_key=YOUR_API_KEY